RxDoctor Payments Data

Arsalaan Salehani, MD

Neurological Surgery · Birmingham, ALNPI 1891158366

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,414 of the $7,585 with a category attached, or 71.4%. 19 manufacturers reported payments, led by Stryker at 52.9% of the total. Reporting peaked in 2024 at $4,608 and has fallen 77.8% since, to $1,025 in 2025.

$7,585in general payments, 2019–2025

Across 105 payments — averaging $72.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$4K
  • Boston Scientific$1K
  • Globus Medical$499
  • Medtronic$279
  • Abbott$255
  • Spineology Inc.$207
  • plus $981 from 13 others

What the payments were for

  • Travel & lodging$2,02127%
  • Food & beverage$5,41471%
  • Education$1502%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,585 in reported general payments places this provider in the 75th percentile of 97 neurological surgery providers in Alabama.

See all neurological surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$63,485
Medicare patients
143
Services billed
415

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin63$553
Cyclobenzaprine Hcl93$472
Methocarbamol43$398
Meloxicam87$253
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$199
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$159
Ondansetron Hcl35$147
Gabapentin20$111
Methylprednisolone16$96
Tizanidine Hcl24$70

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →